INTRAOSSEOUS INFUSION DEVICES MARKET ANALYSIS

Intraosseous Infusion Devices Market, By Product Type (FAST 1 Device, FAST x Device, Bone Injection Gun (BIG) Devices, EZ-IO Device, NIO Device, Dieckmann Modified Needle, Jamshidi Needle), By Technology (Manual IO Needles, Battery Powered Driver, Impact Driven Devices), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others (Pre-hospital Emergency Care, Military Hospitals, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Nov 2023
Code : CMI507
Pages :193
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Increasing prevalence of cardiovascular disorders: Increasing incidence of cardiovascular disorders is anticipated to drive the market growth during the forecast period. For instance, in 2022, according to the American Heart Association report titled Heart and Stroke Statistics 2022 Update, more than 356,000 out-of-hospital cardiac arrests (OHCA) are reported annually in the U.S., nearly 90% of the them were fatal. The incidence of EMS-assessed non-traumatic OHCA in people of any age is estimated to 356,461, or nearly 1,000 people each day. Survival to hospital discharge after EMS-treated cardiac arrest languishes at about 10%.

Increasing technologically advanced product launches and approvals: Increasing launches of advanced products is expected to drive the market growth during the forecast period. For instance, in March 2022, PAVmed Inc., a diversified commercial stage medical technology company, announced that physicans at the Clinica Porto Azul in Barranquilla, Columbia, successfully implanted the company’s PORTIO Intraosseous Infusion System in three patients-the first human implants of the device-as part of its IRB-approved first-in-human (FIH) clinical study of upto 40 patients.

Restraints

Restriction for the Patients Suffering from Osteoporosis: The intraosseous infusion devices are difficult to insert into soft tissues that leads to compartment syndrome. This factor is steadily hindering growth rate of the global intraosseous infusion device market. The patient who have osteoporosis are restricted to use these devices, and this also hampers the global intraosseous infusion device market growth. Key players focusing on developing advance products with safety and cost effective which is expected to drive the market growth over the forecast period.